AF solution
Oncology
Immuno Oncology
Anti-Virus
Disease Modeling
Cosmetics
Toxicity
Spatial Biology
Technology Service
Cancer Organoid
Research Service
Others
Organism | Human |
Product Type | Artificial Skin |
Tissue | Skin |
Disease |
Applications
Organism | Human |
Product Type | Artificial Skin |
Tissue | Skin |
Disease |
Applications
Organism | Human |
Product Type | Artificial Skin |
Tissue | Skin |
Disease |
Applications
Organism | Bovine |
Product Type | Tissue |
Tissue | Cornea |
Disease |
Applications
Eye irritation test - BCOP assay (OECD TG 437)
Eye irritation test is in accordance with the Ministry of Food and Drug Safety guidelines, assesses eye irritation potential using bovine corneas.
In vitro eye irritation test (OECD TG492)
Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eyedamage.
Organism | Human |
Product Type | Organoid |
Tissue | Endometrial cancer |
Disease | Endometrial cancer |
Applications
Oncology
The oncology drug efficacy evaluation platform is based on patient-derived organoids(PDOs).
This platform allows for the assessment of the efficacy of oncology agents and immunotherapeutics by utilizing a co-culture system with immune cells from the tumor microenvironment.
Immuno-Oncology
This provides a solution for assessing the effectiveness of immunotherapeutic agents targeting cytotoxic T cells in co-culture with cancer organoids.
Tumormicroenvironment
CAFs promote cancer invasion and metastasis, potentially inducing resistance to anticancer drugs.
Considering these functions of CAFs is crucial for accurately assessing the efficacy of anticancer drugs and developing strategies to address these challenges.
Cancer Vaccine
Lead the future of treatment with our innovative cancer vaccine and mRNA therapy platform.
Discover advanced solutions that provide better health and hope through our cutting-edge technology and scientific approach
Organism | Human |
Product Type | Organoid |
Tissue | Hepatocellular carcinoma, Total necrotic lesion |
Disease | Hepatocellular carcinoma |
Applications
Oncology
The oncology drug efficacy evaluation platform is based on patient-derived organoids(PDOs).
This platform allows for the assessment of the efficacy of oncology agents and immunotherapeutics by utilizing a co-culture system with immune cells from the tumor microenvironment.
Immuno-Oncology
This provides a solution for assessing the effectiveness of immunotherapeutic agents targeting cytotoxic T cells in co-culture with cancer organoids.
Tumormicroenvironment
CAFs promote cancer invasion and metastasis, potentially inducing resistance to anticancer drugs.
Considering these functions of CAFs is crucial for accurately assessing the efficacy of anticancer drugs and developing strategies to address these challenges.
Cancer Vaccine
Lead the future of treatment with our innovative cancer vaccine and mRNA therapy platform.
Discover advanced solutions that provide better health and hope through our cutting-edge technology and scientific approach
Organism | Human |
Product Type | Organoid + T cell + Macrophage |
Tissue | iPSC, ASC |
Disease |
Applications
Fabry’s disease modeling
Inflammatory Bowel Disease (IBD) refers to a chronic condition characterized by inflammation within the gastrointestinal tract, causing inflammation of the intestinal walls.
Intestinal fibrosis model (3D)
Lambda's Intestinal Fibrosis Model addresses these challenges by leveraging high mimetic human intestinal organoids to create a model of inflammatory bowel diseases.
Probiotic adhesion assay (2D)
Lambda provides a 2D platform for gut attachment and allows for the evaluation of probiotics efficacy through gut attachment analysis.
Host-Microbiome study (3D)
Lambda's highly human-mimicking intestinal organoids enable realistic research on the gastrointestinal system and interactions between cells and microorganisms, serving as a versatile tool for drug development and disease research.
Drug absorption assay(2D)
Lambda provides drug absorption evaluation through drug (sample) permeability analysis using hPSC-derived human functional intestinal epithelial cells (hIEC).
Organism | Bovine |
Product Type | Tissue |
Tissue | Cornea |
Disease |
Applications
In vitro eye irritation (OECD TG 437)
Eye irritation test is in accordance with the Ministry of Food and Drug Safety guidelines, assesses eye irritation potential using bovine corneas.
In vitro eye irritation test (OECD TG492)
Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eyedamage.
Organism | Egg |
Product Type | Other |
Tissue | Other |
Disease |
Applications
In vitro eye irritation test (HET-CAM)
The assessment of the degree of irritation is conducted by observingthe visual changes that occur when a test substance is applied to the chorioallantoic membrane of a fertilized.
Organism | Fish |
Product Type | Other |
Tissue | Other |
Disease |
Applications
Parkinson’s disease model
The enhanced mobility effects of candidate substances, as well as their neuroprotective effects on dopaminergic neurons, can be validated within a two-week period through in vivo behavioral and tissue expression phenotyping
Epilepsy model
The anti-seizure effects of the candidate substance can be validated within a two-week period through in vivo behavioral and electroencephalographic (EEG) phenotyping.
Anxiety & depression model
The antidepressant and anxiolytic effects of the candidate substance can be validated within a two-week period through in vivo behavioral phenotyping
Cancer model
The enhanced mobility effects of candidate substances, as well as their neuroprotective effects on dopaminergic neurons, can be validated within a two-week period through in vivo behavioral and tissue expression phenotyping
@ 2024 . All rights reserved
@ 2024 . All rights reserved